Funders › MA › Alzheimer's Disease Research Foundation › 2023
Grants paid by Alzheimer's Disease Research Foundation, tax year 2023
EIN 52-2396428 · Wellesley Hls, MA · Form 990, Schedule I · NTEE H83
In tax year 2023, Alzheimer's Disease Research Foundation (EIN 52-2396428) reported 98 grants paid totaling $23,118,277. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Massachusetts General Hospital Boston, MA | A | $1,955,000 | paid | THE CUREALZ ALZHEIMER'S GENOME PROJECT | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $431,250 | paid | A NEW MODEL OF MICROGLIA GENETIC PERTURBATION IN VIVO TO SCREEN ALL RISK FACTORS ASSOCIATED WITH ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $345,000 | paid | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $345,000 | paid | APOE CONSORTIUM: ROLE OF APOE ISOFORMS IN IMMUNE RESPONSES IN A MODEL OF TAUOPATHY | 202421229349300027 |
| 2023 | Northwestern University Chicago, IL | A | $345,000 | paid | MBC: INTERACTION OF THE MICROBIOME WITH ASTROCYTES AND AMYLOID PATHOLOGY | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $345,000 | paid | BEE: CROSSTALK OF CNS BARRIERS AND CLEARANCE ROUTES IN HOMEOSTASIS AND ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Boston Children's Hospital Boston, MA | A | $344,085 | paid | NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | University of Southern California Los Angeles, CA | A | $301,069 | paid | AIR POLLUTION AND AD RISK INTERACT WITH PREMATURE AGING OF NEURAL STEM CELLS AND APOE ALLELES | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $300,000 | paid | UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY | 202421229349300027 |
| 2023 | Massachusetts Institute of Technology Cambridge, MA | A | $300,000 | paid | CIRCUITS: DISSECTING MICROGLIAL STATE DYNAMICS IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Boston University Boston, MA | A | $287,500 | paid | APOE CONSORTIUM: MODULATION OF SELECTIVE NEURONAL VULNERABILITY IN ALZHEIMER'S DISEASE BY APOE | 202421229349300027 |
| 2023 | University of California San Diego La Jolla, CA | A | $287,500 | paid | NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION | 202421229349300027 |
| 2023 | Weill Cornell New York, NY | A | $287,500 | paid | BEE: BIOCHEMICAL AND FUNCTIONAL ANALYSIS OF CSF AND LYMPH FOLLOWING CHANGES IN BRAIN FLUID DYNAMICS | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $287,500 | paid | APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $287,500 | paid | MBC: MICROBIAL PROFILING OF HUMAN BRAIN AND GUT MICROBIOMES IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $287,500 | paid | MBC: HARNESSING DIET-MICROBE INTERACTIONS TO PREVENT ALZHEIMER'S DISEASE PATHOGENESIS | 202421229349300027 |
| 2023 | University of California San Diego La Jolla, CA | A | $287,500 | paid | BEE: IDENTIFYING THE BLOOD-BRAIN BARRIER CHANGES DURING ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $287,500 | paid | MBC: THE ROLE OF GUT MICROBIAL METABOLISM IN TAU-MEDIATED NEURODEGENERATION | 202421229349300027 |
| 2023 | University of California Irvine Irvine, CA | A | $287,493 | paid | NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $287,169 | paid | ADTC: HOW DO SOLUBLE TAU SPECIES REPLICATE? | 202421229349300027 |
| 2023 | University of Texas Southwestern Medical Center Dallas, TX | A | $287,000 | paid | ADTC: ROLE OF VCP/P97 IN TAU PRION REPLICATION | 202421229349300027 |
| 2023 | Northwestern University Chicago, IL | A | $286,448 | paid | ADTC: THE ROLE OF A-INDUCED MEMBRANE DAMAGE IN TAU PATHOLOGY | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $258,750 | paid | FUNCTIONAL CHANGES TO CEREBROSPINAL FLUID IMMUNE CELLS RESULTING FROM BACILLUS CALMETTE-GURIN (BCG) VACCINATION IN OLDER ADULTS WITH AND WITHOUT ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | University of Chicago Chicago, IL | A | $250,000 | paid | MBC: TEMPORAL RELATIONSHIPS BETWEEN GUT DYSBIOSIS, BRAIN AB METABOLISM AND MICROGLIA CELL ACTIVATION FOLLOWING ANTIBIOTIC TREATMENT | 202421229349300027 |
| 2023 | Weill Cornell New York, NY | A | $250,000 | paid | DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | University of Southern California Los Angeles, CA | A | $250,000 | paid | CELLULAR AND MOLECULAR STUDIES OF APOE REGULATION OF BLOOD-BRAIN BARRIER, SYNAPTIC AND NEURONAL FUNCTIONS AND PROTECTION STRATEGIES IN MOUSE MODELS WITH AND WITHOUT ALZHEIMER'S PAHTOLOGY | 202421229349300027 |
| 2023 | University of Southern California Los Angeles, CA | A | $234,709 | paid | PROTECTION AGAINST APOE4 WITH LONGEVITY-PROMOTING INTERVENTIONS | 202421229349300027 |
| 2023 | University of Connecticut Farmington, CT | A | $230,000 | paid | AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $230,000 | paid | BEE: A 3D IN-VITRO NEURO-VASCULAR HUMAN BRAIN MODEL WITH MENINGEAL LYMPHATICS FOR ELUCIDATING MECHANISMS UNDERLYING ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | University of California Irvine Irvine, CA | A | $230,000 | paid | ENDOGENOUS HUMAN ANTIBODIES ASSOCIATED WITH ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | University of Texas Southwestern Medical Center Dallas, TX | A | $230,000 | paid | RNA AS A DETERMINANT OF TAU SEEDING | 202421229349300027 |
| 2023 | Memorial Sloan Kettering Cancer Center New York, NY | A | $230,000 | paid | THE ROLE OF IFITM3 AND Y-SECRETASE IN MICROGLIA | 202421229349300027 |
| 2023 | University of California San Diego La Jolla, CA | A | $230,000 | paid | APP GENE DOSE-MEDIATED DYSREGULATION OF THE ENDOLYSOSOMAL NETWORK ACTS COMPROMISE SYNAPTIC STRUCTURE AND FUNCTION LEADING TO ALZHEIMER'S DISEASE IN DOWN SYNDROME | 202421229349300027 |
| 2023 | Duke University School of Medicine Durham, NC | A | $229,994 | paid | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES | 202421229349300027 |
| 2023 | Harvard Medical School Cambridge, MA | A | $220,071 | paid | ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | New York University New York, NY | A | $208,033 | paid | MECHANISMS OF ASTROCYTE-DERIVED LIPID TOXICITY IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Yale University New Haven, CT | A | $204,081 | paid | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI | 202421229349300027 |
| 2023 | Columbia University New York, NY | A | $201,501 | paid | NEUROPROTEASOMES MECHANISTICALLY CONNECT APOE ISOFORMS TO ENDOGENOUS TAU AGGREGATION | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $201,250 | paid | NEUROIMMUNE CONNECTOME PERTURBATIONS IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | VALIDATION AND CHARACTERIZATION OF COMPOUNDS MODULATING NEUROINFLAMMATION AND AMYLOID BETA UPTAKE IN MICROGLIAL CELLS | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | ROLE OF CD8+ T CELL-GLIAL INTERACTIONS IN MEDIATING ALZHEIMER'S DISEASE PATHOGENESIS | 202421229349300027 |
| 2023 | Emory University Atlanta, GA | A | $201,250 | paid | MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION | 202421229349300027 |
| 2023 | University of Southern California Los Angeles, CA | A | $201,250 | paid | PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $201,250 | paid | ROLE OF CHECKPOINT MOLECULES TIM-3 AND LAG-3 IN MICROGLIAL FUNCTION IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $201,250 | paid | CONTRIBUTION OF SKULL BONE MARROW-DERIVED CELLS TO ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | University of Michigan Ann Arbor, MI | A | $201,250 | paid | MORPHOLOGICAL, ELECTROPHYSIOLOGICAL, AND TRANSCRIPTIONAL CHARACTERIZATION OF SINGLE NEURONS FROM RESILIENT AND SUSCEPTIBLE MODELS OF HUMAN AD | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $201,250 | paid | TARGETING THE MICROBIOME AND INNATE IMMUNITY IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Mayo Clinic Jacksonville Jacksonville, FL | A | $201,250 | paid | EVALUATING TMEM106B ACCUMULATION IN AD | 202421229349300027 |
| 2023 | University of Texas Health Science Center at San Antonio San Antonio, TX | A | $201,250 | paid | IDENTIFICATION AND VALIDATION OF PLASMA-BASED LIPID BIOMARKERS FOR EARLY ALZHEIMER'S DISEASE IN THE UNIQUE, PRIMARILY HISPANIC, SOUTH TEXAS POPULATION | 202421229349300027 |
| 2023 | Mayo Clinic Jacksonville Jacksonville, FL | A | $201,250 | paid | RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | ROLE OF RIN3 AND BIN1 INTERACTION IN THE NEURONS FOR ALZHEIMER'S DISEASE DEVELOPMENT | 202421229349300027 |
| 2023 | University of Virginia Charlottesville, VA | A | $201,250 | paid | ELUCIDATING THE ROLE OF CLEC7A IN TAU-MEDIATED NEURODEGENERATIVE DISEASE | 202421229349300027 |
| 2023 | University of Rhode Island Kingston, RI | A | $201,250 | paid | EFFECT OF APOE GENOTYPE IN A NOVEL RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY | 202421229349300027 |
| 2023 | Brigham and Women's Hospital Boston, MA | A | $201,250 | paid | TARGETING NEUROINFLAMMATION WITH NASAL ADMINISTRATION OF ANTI-CD3 MONOCLONAL ANTIBODY TO TREAT ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | ROLE OF STABILIZATION OF MAMS AND MAM-ASSOCIATED PALMITOYLATED APP (MAM-PALAPP) IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Weill Cornell New York, NY | A | $201,250 | paid | IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS | 202421229349300027 |
| 2023 | Tufts University Boston, MA | A | $201,250 | paid | MULTIDISCIPLINARY PHENOTYPING OF A NOVEL HUMANIZED LOAD MOUSE MODEL | 202421229349300027 |
| 2023 | The Salk Institute for Biologial Studies La Jolla, CA | A | $201,250 | paid | TO ELUCIDATE THE ROLE OF MEMORY T CELLS AS A DETERMINANT OF AGE-RELATED INFLAMMATION IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | CHARACTERIZING GUT BACTERIOME-MYCOBIOME SYNERGY IN CORRELATION TO AMYLIN-A ANTIMICROBIAL SYNERGY IN ALZHEIMER'S DISEASE (AD) IN AD MOUSE MODELS | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | GROWTH, CHARACTERIZATION, AND DISTRIBUTION OF A NEURODEGENERATIVE DISEASE-FOCUSED FIBROBLAST/IPS CELL BANK TO SUPPORT MOLECULAR MODELS OF PATIENT-SPECIFIC VARIATION WITH VALIDATION IN MATCHED DONATED BRAIN TISSUES | 202421229349300027 |
| 2023 | Icahn Scool of Medicine at Mount Sinai New York, NY | A | $201,250 | paid | INVESTIGATING LYSOSOMAL MECHANISMS OF RISK AND RESILIENCE IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Mayo Clinic Jacksonville Jacksonville, FL | A | $201,250 | paid | ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Mayo Clinic Jacksonville Jacksonville, FL | A | $201,250 | paid | ELUCIDATING THE PROTECTIVE EFFECTS OF APOE2 IN THE PRESENCE OF APOE4 GENE ALLELE IN ANIMAL MODELS | 202421229349300027 |
| 2023 | Icahn Scool of Medicine at Mount Sinai New York, NY | A | $201,250 | paid | INVESTIGATING MEF2C TRANSCRIPTION FACTOR AS THERAPEUTIC TARGET TO REPROGRAM PATHOLOGICAL MICROGLIAL STATES IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Columbia University New York, NY | A | $201,250 | paid | NONCODING TRANSLATION FEEDBACK LOOP IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Weill Cornell New York, NY | A | $201,250 | paid | TAU-INDUCED POSTSYNAPTIC DYSFUNCTION IN TAUOPATHY MODELS | 202421229349300027 |
| 2023 | The Regents of the University of Califormia San Francisco San Francisco, CA | A | $201,250 | paid | NEURONAL MECHANISMS DRIVING SYNAPSE LOSS IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $201,250 | paid | CHARACTERIZATION OF CNS-PENETRANT HDAC11-SELECTIVE INHIBITORS IN ALZHEIMER'S DISEASE MODELS | 202421229349300027 |
| 2023 | Stanford University Redwood City, CA | A | $201,250 | paid | MULTIOMICS CHARACTERIZATION OF TAU PATHOLOGY ONSET AND ITS RELATIONSHIP WITH AMYLOID IN THE HUMAN HIPPOCAMPUS | 202421229349300027 |
| 2023 | University of Virginia Charlottesville, VA | A | $201,250 | paid | EXPLORING THE THERAPEUTIC POTENTIAL OF CLUSTERIN IN A PRECLINICAL MODEL OF ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $201,250 | paid | DISSECTING ALZHEIMER'S DISEASE PHENOTYPES IN DIRECTLY REPROGRAMMED PATIENT-DERIVED NEURONS | 202421229349300027 |
| 2023 | Johns Hopkins University Baltimore, MD | A | $201,250 | paid | HUMAN BRAIN CD33 LIGAND, RPTPS3L, LIMITS MICROGLIAL PHAGOCYTOSIS AND CONTRIBUTES TO ALZHEIMER'S DISEASE PROGRESSION | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $201,248 | paid | ANTIVIRAL T CELLS INFILTRATION TO THE MENINGES AND BRAIN INFLUENCES NEURODEGENERATION IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | The Methodist Hospital Foundation Houston, TX | A | $201,199 | paid | A MUTI-MODALITY STUDY ON LIPID MOLECULAR BASIS OF OBESITY AND ITS ROLES IN REGULATING ALZHEIMER'S PATHOGENESIS FOR DEVELOPING POTENTIAL TARGETED INTERVENTIONS | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $198,994 | paid | CIRCADIAN DESYNCHRONY, GLIAL DYSFUNCTION, AND ALZHEIMER'S DISEASE PATHOGENESIS | 202421229349300027 |
| 2023 | Stanford University Redwood City, CA | A | $198,751 | paid | OLIGODENDROGLIAL DYNAMICS AND MYELINATION IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Duke University School of Medicine Durham, NC | A | $195,434 | paid | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMER'S PATHOLOGY IN MICE | 202421229349300027 |
| 2023 | University of Virginia Charlottesville, VA | A | $192,020 | paid | TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $189,902 | paid | DECIPHERING AND RESTORING COMPUTATIONAL SET-POINTS IN ALZHEIMER'S DISEASE THROUGH SLEEP-ENHANCED NETWORK HOMEOSTASIS | 202421229349300027 |
| 2023 | Boston Children's Hospital Boston, MA | A | $189,750 | paid | NEUROINFLAMMATION AT THE CHOROID PLEXUS IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Broad Institute Cambridge, MA | A | $172,550 | paid | REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $172,500 | paid | UNDERSTANDING THE ROLE OF NATURAL A-SPECIFIC B CELL RESPONSES IN AD PROGRESSION | 202421229349300027 |
| 2023 | Icahn Scool of Medicine at Mount Sinai New York, NY | A | $172,500 | paid | INVESTIGATING BONE MARROW HEMATOPOIESIS AND THE LINK BETWEEN SLEEP FRAGMENTATION AND VASCULAR INFLAMMATION IN AD | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $172,500 | paid | TAU AND -AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL PEPTIDES IN THE BRAIN | 202421229349300027 |
| 2023 | The Salk Institute for Biologial Studies La Jolla, CA | A | $172,500 | paid | THE ROLE OF ASTROCYTE-SECRETED IGFBP2 IN THE PROGRESSION OF ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Icahn Scool of Medicine at Mount Sinai New York, NY | A | $172,500 | paid | STRESS AND NEUROVASCULAR-IMMUNE NETWORKS IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Northwestern University Chicago, IL | A | $172,500 | paid | T CELL EPIGENETICS IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Icahn Scool of Medicine at Mount Sinai New York, NY | A | $172,500 | paid | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Mayo Clinic Jacksonville Jacksonville, FL | A | $172,500 | paid | TARGETING MICROGLIAL TSG 101 FOR SYNAPTIC PROTECTION AND COGNITIVE ENHANCEMENT IN ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $172,000 | paid | REGIONAL VARIABILITY OF PATHOLOGY-ASSOCIATED PROPERTIES OF TAU IN POSTERIOR CORTICAL ATROPHY | 202421229349300027 |
| 2023 | Harvard Medical School Cambridge, MA | A | $150,000 | paid | PRECISION MEDICINE PREDICTION MODEL FOR ALZHEIMER'S DISEASE USING COOPERATIVE LEARNING APPROACHES FOR MULTI-OMIC DATA | 202421229349300027 |
| 2023 | Northwestern University Chicago, IL | A | $136,827 | paid | INTERROGATING LEVETIRACETAM'S IMPACT ON AMYLOID PATHOLOGY AND PRESYNAPTIC PROTEOSTASIS IN KNOCK-IN MOUSE MODELS WITH HUMANIZED ABETA | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $125,000 | paid | THE IMPACT OF MUTATIONS IN THE LIGAND-BINDING DOMAIN OF CD33 ON ALZHEIMER'S DISEASE PATHOGENESIS | 202421229349300027 |
| 2023 | Beth Israel Deaconess Medical Center Boston, MA | A | $118,450 | paid | AGP: GENOMIC VARIANT CALLING AND DATA MANAGEMENT FOR THE CURE ALZHEIMER'S FUND ALZHEIMER'S GENOME PROJECT | 202421229349300027 |
| 2023 | Washington University St Louis, MO | A | $113,655 | paid | CHARACTERIZATION OF MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOGICAL CONTINUUM | 202421229349300027 |
| 2023 | Massachusetts General Hospital Boston, MA | A | $95,594 | paid | GENERAL SCIENTIFIC SUPPORT | 202421229349300027 |
| 2023 | University of Michigan Ann Arbor, MI | A | $57,500 | paid | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE | 202421229349300027 |
| 2023 | Harvard Medical School Boston, MA | A | $40,250 | paid | GENETIC ANCESTRY-SPECIFIC RISK ESTIMATION OF ALZHEIMER'S DISEASE (AD) IN THE APOE REGION | 202421229349300027 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.